Bioinformatic Analysis of L-Asparaginase II from Citrobacter Freundii ۱۱۰۱, Erwinia Chrysanthemi DSM ۴۶۱۰, E. coli BL۲۱ and Klebsiella Pneumoniae ATCC ۱۰۰۳۱

Publish Year: 1396
نوع سند: مقاله ژورنالی
زبان: English
View: 101

This Paper With 12 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_JIML-4-2_006

تاریخ نمایه سازی: 14 مرداد 1402

Abstract:

Backgroung and Aims: L-Asparaginase II is a cornerstone of treatment protocols for acute lymphoblastic leukemia. Only asparaginase II obtained from E. coli K۱۲ and Erwinia chrysanthemi have been used in human as therapeutic drug. The therapeutic effects of asparaginase II from E. coli K۱۲ and Erwinia chrysanthemi is accompanied by side effects. It is desirable to search for other asparaginase II sources with novel properties that could be therapeutic and produce an enzyme with less adverse effects. Materials and Methods: Previously, we performed the in vitro studies, including cloning, sequencing and expression of L-asparaginase II genes (ansB) from Citrobacter freundii ۱۱۰۱, Erwinia chrysanthemi DSM ۴۶۱۰, E. coli BL۲۱ and Klebsiella pneumoniae ATCC ۱۰۰۳۱. In this article, the obtained results were compared bioinformatically. The nucleotide and amino acid sequence alignments were carried out by ClustalW۲. Protein localization and signal peptides were predicted by PSORT and SIG-Pred softwares, respectively. Percentages of hydrophobic and hydrophilic residues were calculated by Genscript software. The physicochemical parameters were computed using Expasy’s ProtParam prediction server. The secondary and ۳D structures were predicted by SOPMA and the online server Phyre۲, respectively. The antigenicity of the asparaginase IIs was predicted using Semi-empirical method. Results: E. coli BL۲۱ and Citrobacter freundii ۱۱۰۱ had the most similarity in physicochemical parameters and antigenicity with E. coli K۱۲. Also, Erwinia chrysanthemi DSM ۴۶۱۰ had the most similarity in physicochemical parameters and antigenicity with Erwinia chrysanthemi. Conclusions: In spite of these similarities with drug types, the potentiality of other low-similar asparaginase IIs should also be determined and compared with drug types.

Authors

Khosrow Aghaiypour

Gene-Bank Department, Razi Vaccine and Serum Research Institute (RVSRI), Karaj, Iran.

Elham Bahreini

Department of Biochemistry, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran.

Shiva Jafari

Gene-Bank Department, Razi Vaccine and Serum Research Institute (RVSRI), Karaj, Iran.

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • . Ekins S, Mestres J, Testa B. In silico pharmacology ...
  • . Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling ...
  • . Katoh K, Misawa K, Kuma KI, Miyata T. MAFFT: ...
  • . Gasteiger E, Hoogland C, Gattiker A, Duvaud SE, Wilkins ...
  • . Pasut G, Sergi M, Veronese FM. Anti-cancer PEG-enzymes: ۳۰ ...
  • . Narta UK, Kanwar SS, Azmi W. Pharmacological and clinical ...
  • . Sanches M, Krauchenco S, Polikarpov I. Structure, substrate complexation ...
  • . Borek۱۰ D, Jaskólski M. Sequence analysis of enzymes with ...
  • . Cedar H, Schwartz JH. Localization of the two L-asparaginases ...
  • . Graham ML. Pegaspargase: a review of clinical studies. Adv ...
  • . Ramya LN, Doble M, Rekha VP, Pulicherla KK. L-Asparaginase ...
  • . Kumar DS, Sobha K. L-Asparaginase from microbes: a comprehensive ...
  • . El-Bessoumy AA, Sarhan M, Mansour J. Production, isolation, and ...
  • . Hüser A, Klöppner U, Röhm KH. Cloning, sequence analysis, ...
  • . Heinemann B, Howard AJ. Production of tumor-inhibitory L-asparaginase by ...
  • . Bahreini E, sabaghi A, Aghaeipour Kh. Cloning, sequencing and ...
  • . Kotzia GA, Labrou NE. L-Asparaginase from Erwinia chrysanthemi ۳۹۳۷: ...
  • . Harms E, Wehner A, Jennings MP, Pugh KJ, Beacham ...
  • . Swain AL, Jaskolski M, Housset D, Rao JK, Wlodawer ...
  • . Guo QL,Wu MS, Chen Z. Comparison of antitumor effect ...
  • . Mohamed ZK, Elnagdy SM, Seufi AE, Gamal M. Cloning ...
  • . Pace CN, Grimsley GR, Scholtz JM. Protein ionizable groups: ...
  • . Gasteiger E, Gattiker A, Hoogland C, Ivanyi I, Appel ...
  • . Schmid FX. Biological Macromolecules: UV-visible Spectrophotometry. Encyc Life Sci ...
  • . Guruprasad K, Reddy BB, Pandit MW. Correlation between stability ...
  • . Kyte J, Doolittle RF. A simple method for displaying ...
  • . Dehouck Y, Gilis D, Rooman M. Database-derived potentials dependent ...
  • . Atsushi IK. Thermostability and aliphatic index of globular proteins. ...
  • . Ferron F, Longhi S, Canard B, Karlin D. A ...
  • . Greenquist AC, Wriston JC. Chemical evidence for identical subunits ...
  • . Swain AL, Jaskólski M, Housset D, Rao JK, Wlodawer ...
  • . Mezentsev YV, Molnar AA, Sokolov NN, Lisitsina VB, Shatskaya ...
  • . Michalska K, Jaskolski M. Structural aspects of L-asparaginases, their ...
  • . Gardy JL, Laird MR, Chen F, Rey S, Walsh ...
  • نمایش کامل مراجع